2019年10月 | サターラ

Blog

ICER’s Unsupported Drug Price Increase Report: An Analysis

We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported…

Certara2019年10月24日

Poster

Development of a PBPK model for the prediction of Amiodarone pharmacokinetics in fed and fasted state using the Advanced Dissolution, Absorption and Metabolism (ADAM) model

Danielle Pillsbury2019年10月22日

Poster

Development of a Permeability-Limited Cardiac Physiologically-Based Pharmacokinetic Model for Predicting Cardiac Exposure

Danielle Pillsbury2019年10月17日

Poster

Dosing corrected for species differences in toxicokinetics using PBPK modelling predicts equivalent reactive metabolite burden following acetaminophen overdose

Danielle Pillsbury2019年10月17日

Poster

Predictive Performance of Caffeine Preterm PBPK Model and Effect of Time-Varying Physiology on Predictions

Danielle Pillsbury2019年10月17日

Poster

Prediction of Drug-Drug Interaction between Phenobarbital and Theophylline in Children using Physiologically-Based Pharmacokinetic Modelling

Danielle Pillsbury2019年10月17日

Poster

Development of a PBPK model for the prediction of Amiodarone pharmacokinetics in fed and fasted state using ADAM model

Danielle Pillsbury2019年10月17日

Poster

The Certara Quantitative Systems Toxicology & Safety (QSTS) Pharma Consortium: Overview and Invitation to Join

Danielle Pillsbury2019年10月17日

Poster

Quantitative Systems Toxicology Approach Integrates Simcyp PBPK and Core Hepatocyte Metabolism: a Case Study with Valproic Acid

Danielle Pillsbury2019年10月16日

Poster

Prediction of mAb disposition in hepatic impairment – Evolocumab as a case study

Danielle Pillsbury2019年10月15日

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software